行情

SILK

SILK

Silk Road Medical
NASDAQ

实时行情|Nasdaq Last Sale

37.68
+1.04
+2.84%
盘后: 37.68 0 0.00% 16:00 11/15 EST
开盘
37.00
昨收
36.64
最高
38.00
最低
36.50
成交量
25.37万
成交额
--
52周最高
51.50
52周最低
27.83
市值
10.82亿
市盈率(TTM)
-47.1471
分时
5日
1月
3月
1年
5年

分析师评级

4位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

SILK 新闻

  • Norwest Venture Partners raises biggest fund as 'dry powder' in VC builds
  • American City Business Journals.1天前
  • Silk Road Medical: Brighter Days Ahead
  • Seeking Alpha - Article.2天前
  • Is Silk Road Medical a Buy?
  • MotleyFool.com.5天前
  • Silk Road Medical to Present at the Stifel 2019 Healthcare Conference
  • GlobeNewswire.11/05 21:05

更多

所属板块

医疗设备、用品及经销
+1.04%
医疗设备和用品
+1.69%

热门股票

名称
价格
涨跌幅

SILK 简况

Silk Road Medical, Inc. is a medical device company. The Company has developed an approach for the treatment of carotid artery disease called transcarotid artery revascularization (TCAR). The Company’s TCAR relies on two concepts - minimally invasive direct carotid access in the neck and high-rate blood flow reversal during the procedure to protect the brain - and combines the benefits of endovascular techniques with fundamental surgical principles. The Company’s ENROUTE Transcarotid Neuroprotection System (NPS) and ENROUTE Transcarotid Stent System are the products for use in TCAR. The ENROUTE Transcarotid Stent is indicated for use in High Surgical Risk patients and is designed to be used in conjunction with the ENROUTE NPS during the TCAR procedure. The ENROUTE Transcarotid NPS is a device used to access the common carotid artery and initiate high rate temporary blood flow reversal to protect the brain from stroke while delivering and implanting the ENROUTE Transcarotid Stent.
展开

Webull提供Silk Road Medical Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。